Global Rank
#46918
Country Rank
#2152
Market Cap
3.67 M
Price
0.031
Change (%)
0.00%
Volume
25,000
Quest PharmaTech's latest marketcap:
3.67 M
As of 06/04/2026, Quest PharmaTech's market capitalization has reached $3.67 M. According to our data, Quest PharmaTech is the 46918th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 3.67 M |
| Revenue (ttm) | 0 |
| Net Income (ttm) | 3.68 M |
| Shares Out | 0 |
| EPS (ttm) | 0.02 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 06/05/2026 |
Market Cap Chart
Data Updated: 06/04/2026
Quest PharmaTech's yearly market capitalization.
Quest PharmaTech has seen its market value grow from $3.28 M to $3.67 M since 2014, representing a total increase of 11.83% and an annual compound growth rate (CAGR) of 0.98%.
| Date | Market Cap($) | Change (%) | Global Rank |
|---|---|---|---|
| 06/04/2026 | $3.67 M | 15.21% | 46918 |
| 12/30/2025 | $4.33 M | 22.69% | 47203 |
| 12/30/2024 | $3.53 M | -49.98% | 46910 |
| 12/28/2023 | $7.05 M | -13.23% | 45249 |
| 12/30/2022 | $8.12 M | -35.69% | 43547 |
| 12/31/2021 | $12.63 M | -58.29% | 41576 |
| 12/31/2020 | $30.28 M | 81.67% | 38433 |
| 12/30/2019 | $16.67 M | 35.87% | 35824 |
| 12/31/2018 | $12.27 M | -12.31% | 34481 |
| 12/29/2017 | $13.99 M | 4.1% | 33012 |
Company Profile
Quest PharmaTech Inc.
Company Overview: Quest PharmaTech Inc. is a pharmaceutical company focused on developing novel therapeutics for targeted cancer treatments.
Key Product Candidates
- Mab AR 9.6: Targets truncated O-glycan on MUC16, with potential applications in pancreatic, colon, leukemia, ovarian, and breast cancer.
- Oregovomab: Currently in Phase III clinical trials for ovarian cancer treatment.
Headquarters: Edmonton, Canada.
Frequently Asked Questions
-
What is Quest PharmaTech's (OTC-QPTFF) current market cap?As of 06/04/2026, Quest PharmaTech (including the parent company, if applicable) has an estimated market capitalization of $3.67 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Quest PharmaTech (OTC-QPTFF) rank globally by market cap?Quest PharmaTech global market capitalization ranking is approximately 46918 as of 06/04/2026. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.